1. Name of the medicinal product Yasmin 0.03 mg/3 mg film-coated tablets 2. Qualitative and quantitative composition Each film-coated tablet contains 0.030 mg ethinylestradiol and 3 mg drospirenone . Excipient with known effect: lactose 46 mg (as lactose monohydrate 48.17 mg) For the full list of excipients, see section 6.1. 3. Pharmaceutical form Film-coated tablet Light yellow, round tablets with convex faces, one side marked with the letters "DO" in a regular hexagon 4. Clinical particulars 4.1 Therapeutic indications Oral contraception The decision to prescribe Yasmin should take into consideration the individual woman's current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Yasmin compares with other combined hormonal contraceptives (CHCs), see sections 4.3 and 4.4. 4.2 Posology and method of administration Method of administration Oral use Posology How to take Yasmin The tablets must be taken every day at about the same time, if ne...
